EBR Systems: Completes interim enrolment for SOLVE trial

EBR Systems Completes interim enrolment for SOLVE trial

  • EBR Systems (EBR) completes interim patient enrolment in the pivotal SOLVE-CRT IDE trial of WiSE
  • The trial is evaluating the safety and efficacy of the WiSE System in up to 300 patients with acute lead failures, chronic lead failures, high-risk upgrades and leadless upgrades
  • WiSE is a wireless, endocardial pacing system for use in stimulating the heart’s left ventricle which is believed to be the more anatomically correct location for pacing equipment
  • EBR has also executed a five-year agreement for a US$50 million (A$72.63 million) growth capital facility with venture debt provider, Runway Growth Capital
  • Shares in EBR are up 41 per cent and were trading at 53 cents at 1:12 pm
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Kulipa Secures $62M to Enhance Stablecoin Card Issuing Infrastructure

Funding aims to strengthen cryptocurrency card services in the growing fintech market.Highlights: Kulipa raises $62M to enhance its...

Visa Launches AI-Powered Dispute Resolution Tools

New tools aim to streamline resolution of payment disputes.Highlights: Visa introduces AI tools for payment dispute resolution.The new...

UK Fintechs Vibepay and SmartLayer Shut Down

Both companies cease operations amidst challenging market conditions.Highlights: Vibepay and SmartLayer have officially ceased operations.The closures are attributed...

Visa and Ramp Boost Bill Pay Automation with Agentic AI

New integration aims to streamline corporate expense management processes.Highlights: Visa and Ramp announce partnership to automate corporate bill...